Advanced search
Publication Cover
mAbs Volume 16, 2024 - Issue 1
Submit an article Journal homepage
808
Views
0
CrossRef citations to date
0
Altmetric
Report

Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations

Melanie Maiera Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany;b Institute of Functional Interfaces, Karlsruhe Institute of Technology, Karlsruhe, GermanyView further author information
,
Linus Weißa Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany;c Institute for Applied Biotechnology, University of Applied Sciences Biberach, Biberach an der Riss, GermanyView further author information
,
Nikolas Zeha Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyView further author information
,
Valerie Schmieder-Todtenhaupta Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyView further author information
,
Alireza Dehghanid Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyView further author information
,
Marius Nicolaus Felixd Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyView further author information
,
Daniel Heinzelmanna Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyView further author information
,
Benjamin Lindnera Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyView further author information
,
Moritz Schmidta Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyView further author information
,
Joey Studtsa Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyView further author information
,
Patrick Schulza Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyView further author information
,
Bernd Reisingerd Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyView further author information
,
Kerstin Ottec Institute for Applied Biotechnology, University of Applied Sciences Biberach, Biberach an der Riss, GermanyView further author information
,
Matthias Franzrebb Institute of Functional Interfaces, Karlsruhe Institute of Technology, Karlsruhe, GermanyView further author information
,
Daniel Lakatosa Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyCorrespondence[email protected]
View further author information
&
Simon Fischera Bioprocess Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, GermanyCorrespondence[email protected]
View further author information
 show all
Article: 2375798 | Received 29 Feb 2024, Accepted 30 Jun 2024, Published online: 10 Jul 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.